These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20342895)

  • 1. Thromboplastin in the urine of normal and hemophilic men.
    TOCANTINS LM; LINDQUIST JN
    Fed Proc; 1947; 6(1 Pt 2):215. PubMed ID: 20342895
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the normalizing effect of urine on the coagulability of blood in hemophilia].
    Alekseenko IF
    Sov Zdravookhr Kirg; 1967; 2():22-5. PubMed ID: 6061202
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemophilia and hemophilia-like diseases caused by deficiencies in plasma thromboplastin factors: anti-hemophilic globulin (AHG), plasma thromboplastin component (PTC) and plasma thromboplastin antecedent (PTA).
    ROSENTHAL RL
    Am J Med; 1954 Jul; 17(1):57-69. PubMed ID: 13171395
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of hemophilic plasma to platelet thromboplastin.
    MANN FD
    J Lab Clin Med; 1956 Jul; 48(1):51-4. PubMed ID: 13332339
    [No Abstract]   [Full Text] [Related]  

  • 6. INACTIVATION OF PATHOLOGICAL INHIBITORS OF INTRINSIC THROMBOPLASTIN BY PROCOAGULANT FROM HUMAN URINE.
    VONKAULLA KN; VONKAULLA E
    Acta Haematol; 1963 Jul; 30():25-34. PubMed ID: 14045901
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON THE INHIBITORY EFFECT OF HEMOPHILIC PLASMA].
    BRUESTER H
    Z Kinderheilkd; 1963 Nov; 88():506-9. PubMed ID: 14109411
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON DISORDERS OF THE 1ST PHASE OF BLOOD COAGULATION IN HEMOPHILIA].
    IZMAILOVA EF; KOTOVSHCHIKOVA MA
    Probl Gematol Pereliv Krovi; 1963 Jun; 8():14-8. PubMed ID: 14070536
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemophilic syndromes; Aggeler's method of preparing plasma and serum fractions containing antihemophilic globulin and the plasma thromboplastin component].
    MARCACCI M
    Riv Ist Sieroter Ital; 1954; 29(1):104-14. PubMed ID: 13168124
    [No Abstract]   [Full Text] [Related]  

  • 10. COAGULATION STUDIES IN HEMOPHILIOID DISEASES: THEIR IMPORTANCE IN TREATMENT PLANNING.
    MEYER I
    J Oral Surg Anesth Hosp Dent Serv; 1964 Jul; 22():324-31. PubMed ID: 14155476
    [No Abstract]   [Full Text] [Related]  

  • 11. [The consumption of antihemophilic globulin and the development of thromboplastin accelerator power in the adsorbed plasma-recalcified serum mixture. The problem of the responsible serum substrate].
    MAYER G; MAYER S; WAITZ R
    Rev Fr Etud Clin Biol; 1961 Nov; 6():924-8. PubMed ID: 14471688
    [No Abstract]   [Full Text] [Related]  

  • 12. [HEMORRHAGIC DIATHESIS CAUSED BY A DEFICIENCY OF PLASMA-THROMBOPLASTIN-ANTECEDENT (PTA)].
    DE VRIES SI; BRAAT-VANSTRAATEN MA
    Ned Tijdschr Geneeskd; 1964 Jan; 108():118-27. PubMed ID: 14141156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of incubation on the anthemophilic globulin of adsorbed plasma and of adsorbed plasma-serum mixture. Absence of true consumption of the anthemophilic globulin and of development of a thromboplastin-accelerator power].
    MAYER G; MAYER S
    C R Seances Soc Biol Fil; 1961; 155():653-6. PubMed ID: 14471691
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of 0.4 per cent cadmium sulfate on endogenous thromboplastin].
    MARCO-AHUIR R
    Sangre (Barc); 1963; 8():37-66. PubMed ID: 13932887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemophilic syndrome from deficiency of the plasma factors, plasma thromboplastin antecedent and plasma thromboplastin component].
    OLIVI O; MUGNAINI P
    Clin Pediatr (Bologna); 1956 Jan; 38(1):31-44. PubMed ID: 13317098
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study of the thromboplastic activity of normal, hemophilic and thrombocytopenic blood mixture].
    VANACORE C
    Prog Med (Napoli); 1954 Feb; 10(4):109-15. PubMed ID: 13155643
    [No Abstract]   [Full Text] [Related]  

  • 17. [A modification of a method of evaluating the coagulation activity of factor VIII].
    Levchenko LB; Papaian LP; Kotovshchikova MA; Khrolova PV
    Lab Delo; 1989; (5):22-5. PubMed ID: 2473253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of dilution on coagulation of plasma in vitro (normal coagulation, retarded coagulation and hemophilic coagulation].
    GUILLOT M; FIEHRER A; GUIET R
    Sang; 1950; 21(8):732-40. PubMed ID: 14787334
    [No Abstract]   [Full Text] [Related]  

  • 19. [HAGEMAN FACTOR DEFICIENCY].
    VERRASTRO T; COSTA MF; JAMRA M
    Rev Hosp Clin Fac Med Sao Paulo; 1963; 18():511-6. PubMed ID: 14119075
    [No Abstract]   [Full Text] [Related]  

  • 20. Is hemophilia a disease of the tissue factor pathway of coagulation?
    Nemerson Y; Zur M
    Prog Clin Biol Res; 1981; 72():77-83. PubMed ID: 6801686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.